C3 and metabolic syndrome: Beyond blood pressure elevation, C3 dysregulation is also associated with hypertension-related comorbidities such as metabolic syndrome, type 2 diabetes, and atherosclerosis, further highlighting its pathogenic relevance across cardiovascular and metabolic axis [182–184].